🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis...
Status
Completed
Location
Zydus US032
Start Date
2021-08-18
Trial ID
NCT05011305
Treatments Being Tested
A Single-center, Randomized, Blinded, Placebo- and Active-controlled Crosso...
Status
Completed
Location
Cliantha Research Limited
Start Date
2019-08-19
Trial ID
NCT04045769
Treatments Being Tested
This is a phase 2A, single center, open-label, single-arm, 24-week study to...
Status
Completed
Location
Virginia Commonwealth University
Start Date
2019-02-25
Trial ID
NCT03639623
Treatments Being Tested
Saroglitazar Magnesium 4 mg for NAFLD in People Living with HIV in the US...
Status
Terminated
Location
Zydus US004
Start Date
2022-12-08
Trial ID
NCT05211284
Treatments Being Tested
Long-Term Study to Evaluate the Safety and Efficacy in Participants with Pr...
Status
Recruiting
Location
Zydus US104
Start Date
2026-03-24
Trial ID
NCT07216235
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study in up to 104 p...
Status
Completed
Location
Precision Research
Start Date
2017-04-06
Trial ID
NCT03061721
Treatments Being Tested
This will be a Phase I, open-label, nonrandomized, single-dose study in hea...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2019-09-20
Trial ID
NCT04112446
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study to evaluate sa...
Status
Completed
Location
Southern Therapy and Advanced Research (STAR) LLC
Start Date
2019-06-12
Trial ID
NCT03863574
Treatments Being Tested
To evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2, and 4 m...
Status
Suspended
Location
Medical Affiliated Research Center, Inc.
Start Date
2017-04-06
Trial ID
NCT03097107
Treatments Being Tested
This is a multicenter, phase 2A, randomized, double-blind, placebo-controll...
Status
Terminated
Location
Zydus US005
Start Date
2019-02-12
Trial ID
NCT03617263
Treatments Being Tested